VIR - U.S. to share government-backed COVID-19 tech with WHO - Washington Post

The Biden administration is planning to share U.S. government-devised COVID-19 technologies with the World Health Organization (WHO), The Washington Post reported Thursday, citing people familiar with the matter. However, the plan to be announced Thursday morning by Health and Human Services Secretary Xavier Becerra, will exclude the technologies used in currently available vaccines and treatments developed by private companies, according to the people. Specifically, the government is not expected to share the technology behind the COVID-19 vaccine designed by Moderna (NASDAQ:MRNA) in partnership with the U.S. National Institutes of Health (NIH). In addition to Moderna (MRNA -4.4%), Novavax (NVAX -5.6%) also received government backing for the development of its COVID-19 vaccine. Other drugmakers with U.S.-authorized COVID-19 vaccines are Pfizer (PFE +0.9%)/BioNTech (BNTX -4.5%) and Johnson & Johnson (JNJ +1.0%). Last December, the U.S. Food and Drug Administration (FDA) authorized COVID-19 pills developed by Pfizer (PFE +0.9%) and Merck (MRK +0.2%)

For further details see:

U.S. to share government-backed COVID-19 tech with WHO - Washington Post